ATC codes:
L02AE02
Indication
Malignant neoplasms of prostate
ICD11 code:
2D32.Z
INN
Leuprorelin
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IM:
7.5 mg in prefilled syringe ;
22.5 mg in prefilled syringe
EML status history
First added in 2015
(TRS
994)
Changed in 2021
Sex
Male
Age
Adolescents and adults
Therapeutic alternatives
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended goserelin and triptorelin be specified as therapeutic alternatives under the square box listing for leuprorelin on the EML.